The intron 6 G/T polymorphism of c-myb oncogene and the risk for coronary in-stent restenosis

Basic Research in Cardiology

Volumn 99, Issue 4, 2004, Pages 309-314

  Gross, C Michael ^a   Krämer, Jochen ^a   Pfeufer, Arne ^a   Dietz, Rainer ^a   Geßner, Reinhard ^a   Praus, Michael ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

C myb oncogene; Coronary artery disease; In stent restenosis; Polymorphism; Smooth muscle cell proliferation

Indexed keywords

GUANINE; HYBRID PROTEIN; LIPID; PROTEIN C MYB; THYMINE;

ADENOVIRUS; ALLELE; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL DIAMETER; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY STENT; DEVICE; DIABETES MELLITUS; DNA POLYMORPHISM; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; GENOTYPE; HUMAN; HUMAN CELL; INTRON; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; MUTANT; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE C MYB; RESTENOSIS; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SMOOTH MUSCLE FIBER; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VIRUS RECOMBINANT;

EID: 3142727193     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-004-0475-6     Document Type: Article

References (29)

1. Badiani P, Corbella P, Kioussis D, Marvel J, Weston K (1994) Dominant interfering alleles define a role for c-Myb in T-cell development. Genes Dev 8: 770-782
2. Baim DS, Levine MJ, Leon MB et al. for the U.S. Palmaz-Schatz Stent Investigators (1993) Management of restenosis within the Palmaz-Schatz coronary stent: the U.S. multicenter experience. Am J Cardiol 71: 364-366
3. Bassam BJ, Caetano-Anolles G, Gresshoff PM (1991) Fast and sensitive silver staining of DNA in polyacrylamide gels. Annal Biochem 196: 80-803
4. Bett AJ, Krougliak V, Graham FL (1995) DNA sequence of the deletion/insertion in early region 3 of Ad5dl 309. Virus Res 39: 75-82
5. Brown KE, Kindy MS, Sonenshein GE (1992) Expression of the c-myb protooncogene in bovine vascular smooth muscle cells. J Biol Chem 267: 4625-4630
6. Dalton ML, Gadson PF Jr, Wrenn RW, Rosenquist TH (1997) Homocysteine signal cascade: production of phospholipids, activation of protein kinase C, and the induction of c-fos and c-myb in smooth muscle cells. Faseb J 11: 703-711
7. Dauerman HL, Baim DS, Cutlip DE et al. (1998) Mechanical debulking versus balloon angioplasty for the treatment of diffuse in-stent restenosis. Am J Cardiol 82: 277-284
8. Fischman DL, Leon MB, Baim DS et al. (1994) A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Eng J Med 331: 496-501
9. Gerard RD, Meidell RS (1995) Adenovirus vectors. In: Hames BD, Glover D (eds) DNA Cloning-A Practical Approach: Mammalian Systems. Oxford University Press, Oxford, pp 285-307
10. Gonda TJ (1998) The c-Myb oncoprotein. Int J Biochem Cell Biol 30: 547-551
11. Grewe PH, Deneke T, Machraoui A, Barmeyer J, Muller KM (2000) Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol 35: 157-163
12. Gross CM, Krämer J, Weingärtner O et al. (2000) Clinical and angiographic outcome in patients with in-stent restenosis and repeat target lesion revascularization in small coronary arteries. Heart 84: 307-313
13. Gunn J, Holt CM, Francis SE, Shepherd L, Grohmann M, Newman CM, Crossman DC, Cumberland DC (1997) The effect of oligonucleotides to c-myb on vascular smooth muscle cell proliferation and neointima formation after porcine coronary angioplasty. Circ Res 80: 520-531
14. Husain M, Jiang L, See V, Bein K, Simons M, Alper SL, Rosenberg RD (1997) Regulation of vascular smooth muscle cell proliferation by plasma membrane Ca (2+)-ATPase. Am J Physiol 272: 1947-1959
15. Kastrati A, Schömig A, Elezi S et al. (1997) Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 30: 1428-1436
16. King SB III, Williams DO, Chougule P et al. (1998) Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: results of the Beta Energy Restenosis Trial (BERT). Circulation 97: 2025-2030
17. Hehrlein C, Arab A, Bode C (2002) Drug-eluting stent: the "magic bullet" for prevention of restenosis? Basic Res Cardiol 97 (6): 417-423
18. Macejak D, Lin H, Webb S, Chase J, Jensen K, Jarvis TC, Leiden JM, Couture L (1999) Adenovirus-mediated expression of a ribozyme to c-myb mRNA inhibits smooth muscle cell proliferation and neointima formation in vivo. J Virol 73: 7745-7751
19. Marhamati DJ, Bellas RE, Arsura M, Kypreos KE, Sonenshein GE (1997) A-myb is expressed in bovine vascular smooth muscle cells during the late G1to-S phase transition and cooperates with c-myc to mediate progression to S phase. Mol Cell Biol 17: 2448-2457
20. Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA, Pietryga DW, Scott WJ Jr, Potter SS (1991) A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65: 677-689
21. Nabel EG (1995) Gene therapy for vascular diseases. Atherosclerosis 118 (Suppl): 51-56
22. Reilly CF, Kindy MS, Brown KE, Rosenberg RD, Sonenshein GE (1989) Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle. Biol Chem 264: 6990-6995
23. Rushton JJ, Davis LM, Lei W, Mo X, Leutz A, Ness SA (2003) Distinct changes in gene expression induced by A-Myb, B-Myb and c-Myb proteins. Oncogene 22: 308-313
24. Ryan TJ, Faxon DP, Gunnar RM et al. (1988) Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/ American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures. Circulation 78: 486-502
25. Schmitt J, Keogh MC, Dennehy U, Chen D, Lupu F, Weston K, Taylor D, Kakkar V, Lemoine N (1999) Tissue-selective expression of dominant-negative proteins for the regulation of vascular smooth muscle cell proliferation. Gene Ther 6: 1184-1191
26. Serruys PW, de Jaegere P, Kiemeneij F et al. (1994) A comparison of expandablestent implantation with balloon angioplasty in patients with coronary artery disease. N Eng J Med 331: 489-495
27. Simons M, Edelman ER, DeKeyser JL, Langer R, Rosenberg RD (1992) Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 359: 67-70
28. Teirstein PS, Massullo V, Jani S et al. (1997) Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Eng J Med 336: 1697-1703
29. Yokota J, Tsunetsugu-Yokota Y, Battifora H, Le Fevre C, Cline MJ (1986) Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation. Science 231: 261-265